ANC-501

DB18907InvestigationalSmall molecule

ANC-501 is under investigation in clinical trial NCT05439603 (ANC-501 in the Treatment of Adults With Major Depressive Disorder).

Chemical structure of ANC-501
Mechanism
Curator reviewed
Formula / weight
C25H30ClN5O3 · 484.0 g/mol (avg)
Also known as
3-(3-Chlorophenyl)-1,5-dihydro-N-(1-methylethyl)-1-[4-[2-(4-morpholinyl)ethyl]phenyl]-5-oxo-4H-1,2,4-triazole-4-acetamide
Code names
ANC-501 · THY-1773 · TS-121

Resolves to

Compound
UNII575OB1CKN0CAS1370444-22-6
Structure
InChIKeyYCLGGNJZGIFVKX-UHFFFAOYSA-NSMILESCC(C)NC(=O)CN1C(=O)N(N=C1C1=CC=CC(Cl)=C1)C1=CC=C(CCN2CCOCC2)C=C1
Targets
P47901AVPR1B

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with ANC-501, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In